Release
2026/10/30
OSAKA, Japan, October 30, 2026 - Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announced that there have been corrections made to the above-mentioned disclosure material released on October 29, 2026. Please note that this matter resulted solely from an error in the disclosure and has no impact on either the financial statements or the consolidated financial statements. In addition, as corrections are also required to the numerical data (XBRL), we will submit the corrected numerical data accordingly.
1. Details of corrections
The corrections are set out below. The corrected portions are underlined.
(Before Correction)
|
Revenue |
Operating profit |
Profit before tax |
Profit attributable to owners of parent |
Basic earnings per share (yen) |
Previous forecasts (A) |
700,000 |
220,000 |
220,000 |
210,000 |
246.79 |
Revised forecasts (B) |
720,000 |
230,000 |
220,500 |
212,500 |
249.67 |
Change (B − A) |
+20,000 |
+10,000 |
+500 |
+2,500 |
− |
Change (%) |
+2.9 |
+4.5 |
+0.2 |
+1.2 |
− |
[Reference] Results for the fiscal year ended March 31, 2026 |
499,677 |
170,306 |
242,497 |
209,244 |
245.91 |
[Reference] Y on Y change (%) |
+46.1 |
+35.1 |
−9.1 |
+1.6 |
− |
(After Correction)
|
Revenue |
Operating profit |
Profit before tax |
Profit attributable to owners of parent |
Basic earnings per share (yen) |
Previous forecasts (A) |
700,000 |
220,000 |
220,000 |
210,000 |
246.79 |
Revised forecasts (B) |
720,000 |
230,000 |
220,500 |
212,500 |
249.67 |
Change (B − A) |
+20,000 |
+10,000 |
+500 |
+2,500 |
− |
Change (%) |
+2.9 |
+4.5 |
+0.2 |
+1.2 |
− |
[Reference] Results for the fiscal year ended March 31, 2026 |
499,677 |
170,306 |
242,497 |
209,244 |
245.91 |
[Reference] Y on Y change (%) |
+44.1 |
+35.1 |
−9.1 |
+1.6 |
− |
2. Reason for corrections
We have identified discrepancies between certain figures presented in our “Notice of Revisions to Earnings Forecasts and Dividend Forecasts (Dividend Increase)”, announced on October 29, 2026, and those presented in our “Consolidated Financial Results for the Second Quarter of Fiscal Year 2026 (IFRS),” announced on the same date.
Forward-Looking Statements
This announcement contains forward-looking statements. These statements are based on expectations in light of the information currently available, assumptions that are subject to risks and uncertainties which could cause actual results to differ materially from these statements. Risks and uncertainties include general domestic and international economic conditions such as general industry and market conditions, and changes of interest rate and currency exchange rate. These risks and uncertainties particularly apply with respect to product-related forward-looking statements. Product risks and uncertainties include, but are not limited to, completion and discontinuation of clinical trials; obtaining regulatory approvals; claims and concerns about product safety and efficacy; technological advances; adverse outcome of important litigation; domestic and foreign healthcare reforms and changes of laws and regulations. Also for existing products, there are manufacturing and marketing risks, which include, but are not limited to, inability to build production capacity to meet demand, lack of availability of raw materials and entry of competitive products. The company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
For Further Information, Contact:
SHIONOGI Website Inquiry Form : https://www.shionogi.com/global/en/contact.html